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Abstract 
Cardiovascular diseases are the most common cause of death in developed countries. Blood measurement is an integral 
part of the diagnosis of these diseases. With the development of oscillometric blood pressure monitors, the question of 
regular monitoring of their clinical accuracy (overall error) has arisen. This paper deals with the overall accuracy of 
two commercial tonometers (Hartmann Digital HG 160 comfort and HuBDIC HBP–1520), using two calibrated blood 
pressure simulators (Fluke BP Pump 2 and Fluke ProSim). Using the Wilcoxon rank-sum test, significant differences 
between the simulators have been proved for all measurements—both for SBP and DBP measurements and both for 
Hartmann Digital HG 160 and HuBDIC HBP–1520 tonometers (p < 0.001). Therefore, without the precise knowledge 
of the relationship between the blood pressure monitor and the simulator used, it is not appropriate to use simulators to 
determine the overall error. On the other hand, the tested devices had a very good repeatability of the measurements at 
all presets, with both simulators. From this point of view, it is suitable to use simulators to determine the stability of 
measurement by a given tonometer rather than its clinical accuracy. 
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Introduction 
Cardiovascular diseases are well known as one of the 
leading causes of death in developed countries. The 
risk of coronary, cerebral or peripheral artery diseases 
closely relates to creeping changes in the cardiovascular 
system such as atherosclerosis or hypertension [1]. At 
the same time, the prevalence of arterial hypertension is 
about 44% in European countries and about 28% in the 
United States [2]. Together with the ageing of the popu-
lation in developed countries, which is well-documented 
[3], the hypertension is a significant danger and should 
be monitored carefully. Furthermore, many of the hyper-
tension patients are not aware of their disease [4], and 
the numbers could be higher in fact. In all cases, the 
therapy of hypertension requires an accurate and reliable 
measurement of blood pressure. 
In 1987, a protocol for evaluating the clinical accuracy 
of devices for the blood pressure measurement was pub-
lished by the American Association for the Advance-
ment of Medical Instrumentation (AAMI) [5]. Conse-
quently, a protocol for validating the blood pressure 
monitors was also published by the British Hypertension 
Society (BHS) in 1990 [6]. The revised version of the 
BHS protocol was published in 1993 [7]. In 2010, the 
European Society of Hypertension (ESH) published 
International Protocol revision 2010 for the validation 
of blood pressure measuring devices in adults which 
combines and simplifies the AAMI and BHS require-
ments [8]. Finally, the AAMI, ESH and International 
Organization for Standardization (ISO) declared a con-
sensus on preparing of Universal Standard for the Vali-
dation of Blood Pressure Measuring Devices in 2018 
[9]. A blood pressure monitor could be recommended 
for clinical use if the AAMI criteria both for systolic 
(SBP) and diastolic (DBP) pressures are met (the differ-
ence between the device and the mercury standard is 
lower than 5 mmHg) and if the device received a grade 
of A or B based on the BHS protocol. These protocols 
reacted to the rapid development of so-called automated 
non-invasive blood pressure monitors (within the mean-
ing of this article, blood pressure monitors and sphyg-
momanometers are understood to be the same) and to 
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the need of determining the clinical accuracy of these 
devices that the most commonly use the oscillometric 
method [10]. 
The basic safety requirements and the necessary func-
tionality of the automated non-invasive blood pressure 
monitors are described in EN 80601–2–30 + A1 [11]. In 
this standard, there is a requirement for a maximum cuff 
pressure error that cannot be greater than ±3 mmHg or 
2% of the readings (greater of these values) over the 
entire measuring range (for temperature between 10 °C 
and 40 °C and relative humidity between 15% to 85% 
without condensation) (see paragraph 201.12.1.102). 
The overall clinical accuracy must then be in accordance 
with EN 81060–2 (see 201.106) [12]. 
In addition to production itself, regular checks of these 
monitors are also important. According to EN 80601–2–
30 + A1 [11], regular verification of the accuracy of 
automated non-invasive sphygmomanometers is always 
recommended every two years, or after maintenance or 
repair (see paragraph 201.7.9.2.13). This verification is 
carried out in a manometric mode (see paragraph 
201.12.1.107), which allows the static pressure to be 
measured across the whole range of the device. 
However, there is no requirement in this standard to 
verify clinical accuracy, i.e. especially the accuracy of 
the DBP and SBP measurements. 
There are different approaches to regular check and 
verification of automated electronic non-invasive 
sphygmomanometers. In many countries, these devices 
are ranked in terms of their importance for health protec-
tion in the category of “legally controlled measuring 
instruments” (e.g. the Czech Republic and Slovakia), 
for which it is necessary by law to perform regular 
verification of their metrological characteristics (usually 
every two years). The overall verification process 
consists of a series of steps and is based on harmonized 
technical standards (EN 81060–1 [13], EN 1060–3 + A2 
[14] etc.) or, where appropriate, manufacturer's infor-
mation. However, the scope of the verification itself is 
different in some countries. Whereas, for example, in the 
Czech Republic, regular verification of measuring accu-
racy is limited to the accuracy test of the cuff pressure 
indication and the maximum error of the indication of 
the cuff pressure is checked (must be within ±3 mmHg), 
in Slovakia, besides the cuff pressure indication, the 
testing of the total error of the monitor (clinical 
accuracy) is performed by simultaneous comparative 
measurement with a reference auscultation sphygmoma-
nometer in selected individuals (on the same arm ac-
cording to N1 test method EN 1060–4 [15]; this standard 
has already been replaced by EN 81060–2 [12]) and/or 
by comparative measurement with a calibrated blood 
pressure simulator. 
The goal of the study was to assess the suitability of 
using blood pressure simulators to determine the total 
error (clinical accuracy) of automated noninvasive 
sphygmomanometers.
Material  and Methods 
Evaluated Devices 
The devices available in the global market with the 
different type of oscillometric method for blood pressure 
measurement have been selected: 
a) Hartmann Digital HG 160 comfort—an automatic 
device intended for clinical and self-measurement in 
home conditions. The device uses the oscillometric 
method during the deflation of the cuff for measurement 
of blood pressure in the range of 30 to 280 mmHg with 
a declared accuracy of ±3 mmHg [16]. 
b) HuBDIC HBP–1520—an automatic device for 
measurement of NIBP during inflation of the cuff. The 
manufacturer declares that the device measures in the 
range of 40 to 230 mmHg with the accuracy of 
±3 mmHg [17]. 
Performed Tests 
These devices were tested according to the Czech 
metrological regulation MP 017 [18], which determines 
the testing procedure for blood pressure measuring 
devices during their verification and corresponds to the 
standard EN 81060–1 [13] and EN 1060–3 + A2 [14]. 
Specifically, the tests were carried out according to 
Chapter 6.3 concerning the process of metrological 
verification of electronic automated blood pressure 
devices. The following checks and functional tests were 
carried out: 
a) Zero setting control—at zero overpressure in the 
pneumatic system of the device, the display must show 
zero after the device has been switched on. 
b) Rapid exhaust test—in the pneumatic system of the 
device, a positive pressure close to the upper limit of the 
measuring range shall be generated and the quick-
release valve shall be actuated. The time taken for the 
pressure reduction from 260 mmHg to 15 mmHg is 
measured and shall not exceed 10 s. 
c) Air leakage test—in the pneumatic system 
a positive pressure close to the upper limit of the mea-
suring range is generated. After the pressure has stabi-
lized for five minutes, the value of the pressure drop per 
minute is measured using a stopwatch. The decrease 
shall not exceed 6 mmHg/min. The test is performed 
with a cuff wrapped around a cylinder of appropriate 
size. 
d) Cuff pressure indication accuracy test—direct 
comparison of pressure standard reading with tonometer 
reading. Measurements are made in 50 mmHg incre-
ments between 0 mmHg and the upper end of the scale 
range, at both rising and falling pressure (at the same 
pressure points). The maximum permissible error of cuff 
pressure indication over the entire range is 3 mmHg. 
e) In the framework of this article, the total error (i.e. 
overall system accuracy according EN 1060–3 [19],  
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clinical accuracy) of the devices under investigation was 
determined according to paragraph 4.2.2.3 of the Slovak 
Decree No. 210/2000 Coll [20]. The total error is deter-
mined according to this Decree: 
(a) simultaneous repetitive measurement per-
formed by the test and reference auscultation meter on 
the upper arm of the same hand of the selected physi-
cal persons and at the same time, 
(b) a test using a calibrated blood pressure simu-
lator. 
In the method referred to in point (a) the persons must 
be selected so that at least one systolic blood pressure 
value and one diastolic blood pressure value is in the 
high pressure range (>160/>100) mmHg, one in the 
normal pressure range (90–160)/(80–100) mmHg and 
one value in the low pressure range (<100/<80) mmHg. 
In the method referred to in point (b) the minimum 
number of test points is five, with at least one test point 
in each band (high, normal and low pressure). 
According to point 3.3 of the Decree [20], the arith-
metic mean total error of measurements for DBP and 
SBP must be within ±5 mmHg and sample standard 
deviation of measurement must be within ±8 mmHg 
which complies with the requirements of EN 1060–3 
(part 7.9) [19]. If a blood pressure simulator is used, the 
standard deviation must be within ±3 mmHg. The results 
are evaluated according to EN 1060–4 (part 4.9) [15]. 
First of all, blood pressure differences from all paired 
measurements are calculated according to the following 
formulas: 
∆𝑝𝑝SBP = 𝑝𝑝SBPt − 𝑝𝑝SBPs, (1) 
∆𝑝𝑝DBP = 𝑝𝑝DBPt − 𝑝𝑝DBPs, (2) 
where pSBPt is systolic blood pressure value indicated by 
the tonometer under test, pSBPs is systolic blood pressure 
value set on the blood pressure simulator, pDBPt is dias-
tolic blood pressure value indicated by the tonometer 
under test, pDBPs is diastolic blood pressure value set on 
the blood pressure simulator. 
The arithmetic mean error and sample standard 
deviation for SBP and DBP are then calculated as 
∆𝑝𝑝SBP�������� =
1
𝑛𝑛
�∆𝑝𝑝SBP i,
𝑛𝑛
𝑖𝑖=1
 (3) 
∆𝑝𝑝DBP�������� =
1
𝑛𝑛
�∆𝑝𝑝DBP i
𝑛𝑛
𝑖𝑖=1
, (4) 
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1
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 ∆𝑝𝑝DBP��������)2. (6) 
The use of only one of these methods is allowed if the 
properties of the test instrument do not allow the tests to 
be performed by both methods. In that case, this fact 
shall be indicated in the test records. If both methods are 
used, the meter must pass the test according to both 
methods in order to be verified. 
In the case of our tested devices, we did not perform 
the test on individuals according to point (a), because it 
was not possible to measure the auscultation method 
(HuBDIC HBP–1520 measures during cuff inflation, 
Hartmann Digital HG 160 has too rapid deflation). That 
is why we have focused to the test using a calibrated 
blood pressure simulator. 
Calibrated Blood Pressure Simulators 
We tested the total error using two calibrated blood 
pressure simulators, both from FLUKE: 
a) FLUKE BP Pump 2—the device is a blood 
pressure simulator intended for testing of adult and 
neonatal blood pressure monitors. The simulator allows 
to simulate the systolic blood pressure (SBP) in range of 
20 to 250 mmHg, diastolic blood pressure (DBP) in 
range of 10 to 200 mmHg, heart rate in the range of 30 
to 250 bpm (beats per minute) and pulse volume in the 
range of 0.1 to 2.4 ml. The volume of the inner adult cuff 
is 310 ml and 20 ml of the neonatal cuff. The simulator 
provides 22 different presets for simulating blood 
pressure such as a healthy heathy patient, geriatric 
patient, obese patient, a patient with tachycardia, brady-
cardia or atrial fibrillation etc. The preset for healthy 
patient was used for testing of blood pressure measure-
ment repeatability [21]. 
b) FLUKE ProSim 8—the device is a vital signs 
simulator which can also simulate the oscillometric 
pulsations for testing of NIBP measurement devices. 
The device can generate the pressure in the range of 20 
to 400 mmHg; the maximal pulse volume is 1.25 ml. 
Similarly, as BP Pump 2 the simulator provides different 
presets. Identically as for FLUKE BP Pump 2, the preset 
for healthy patient was used for testing of blood pressure 
measurement repeatability [22]. 
Both simulators had metrological traceability to 
pressure standards of the Czech Metrology Institute. The 
static accuracy of both simulators compared to the 
PMI 40K (Cressto, CZ) reference pressure gauge with 
accuracy ±0.3 mmHg, was better than ±1 mmHg in the 
range of measurement 0 to 300 mmHg. The maximum 
expanded standard uncertainty of calibration was 
±0.13 mmHg. 
Statistical Analysis 
The total errors obtained by both simulators has been 
statistically analysed to prove the difference between the 
results acquired by FLUKE BP Pump 2 and FLUKE 
ProSim 8. 
First, the normality of data has been tested by 
Lilliefors test (the hypothesis H0: the data comes from 
a distribution in the normal family) [23]. 
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Consequently, Wilcoxon rank-sum test (Mann-
Whitney U–test) has been used to test the null hypoth-
esis H0 that data obtained using FLUKE BP Pump 2 and 
FLUKE ProSim 8 are samples from continuous distribu-
tions with equal medians, against the alternative that 
they are not [24]. 
Results 
Total Errors 
All measurements were carried out under laboratory 
conditions meeting the requirements of MP 017 [18]. 
Both selected devices met requirements a) to d) 
according to section 2.2. The air leakage was repeatedly 
tested in the whole range. All values for both investi-
gated devices were lower than 6 mmHg/min, which is 
the required value by the regulation [18]. The cuff 
pressure indication accuracy for both devices was better 
than ±3 mmHg in the whole range from 50 mmHg to 
300 mmHg with steps of 50 mmHg, both during 
inflation and deflation of the cuff. 
The total error was evaluated according to the regu-
lation [20]. Both evaluated devices were tested both with 
FLUKE BP Pump 2 [21] and FLUKE Prosim 8 [22] 
simulators. Measurement for each preset was repeated 
five times, and consequently, the arithmetic mean error 
of the measurements and the sample standard deviations 
for seven different presets and for both devices evalu-
ated on each simulator were calculated, see Table 1 to 
Table 4. 
Table 1: Results for the Hartmann Digital HG 160 
evaluated on the FLUKE BP Pump 2 (all values are in 
mmHg). 
preset 𝑝𝑝𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆 ∆𝑝𝑝𝑆𝑆𝑆𝑆𝑆𝑆�������� sSBP 𝑝𝑝𝐷𝐷𝑆𝑆𝑆𝑆𝑆𝑆 ∆𝑝𝑝𝐷𝐷𝑆𝑆𝑆𝑆�������� sDBP 
1 60 2.8 0.8 30 4.4 0.5 
2 80 2.8 0.8 50 4.2 0.4 
3 100 2.0 0.7 65 4.0 0.7 
4 120 2.8 0.4 80 4.8 0.4 
5 150 3.4 0.9 100 6.2 0.8 
6 200 2.0 0.7 150 5.6 0.5 
7 255 0.0 0.0 195 7.6 0.9 
Table 2: Results for the HuBDIC HBP–1520 evaluated 
on the FLUKE BP Pump 2 (all values are in mmHg). 
preset 𝑝𝑝𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆 ∆𝑝𝑝𝑆𝑆𝑆𝑆𝑆𝑆�������� sSBP 𝑝𝑝𝐷𝐷𝑆𝑆𝑆𝑆𝑆𝑆 ∆𝑝𝑝𝐷𝐷𝑆𝑆𝑆𝑆�������� sDBP 
1 60 –0.2 0.4 30 5.4 0.5 
2 80 1.4 0.5 50 –0.2 0.4 
3 100 0.0 0.0 65 0.4 0.9 
4 120 –0.6 0.5 80 1.4 0.5 
5 150 –0.8 0.4 100 1.8 0.4 
6 200 1.2 0.4 150 2.2 0.8 
7 255 1.6 1.5 195 2.6 0.5 
Table 3: Results for the Hartmann Digital HG 160 
evaluated on the FLUKE Prosim 8 (all values are in 
mmHg). 
preset 𝑝𝑝𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆 ∆𝑝𝑝𝑆𝑆𝑆𝑆𝑆𝑆�������� sSBP 𝑝𝑝𝐷𝐷𝑆𝑆𝑆𝑆𝑆𝑆 ∆𝑝𝑝𝐷𝐷𝑆𝑆𝑆𝑆�������� sDBP 
1 60 6.0 0.0 30 6.0 0.0 
2 80 6.2 0.4 50 6.0 0.0 
3 100 6.4 0.5 65 7.4 0.5 
4 120 8.8 0.8 80 9.0 0.0 
5 150 12.6 0.9 100 11.0 0.7 
6 200 15.8 0.8 150 13.0 0.7 
7 255 0.0 0.0 195 15.8 0.4 
Table 4: Results for the HuBDIC HBP–1520 evaluated 
on the FLUKE Prosim 8 (all values are in mmHg). 
preset 𝑝𝑝𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆 ∆𝑝𝑝𝑆𝑆𝑆𝑆𝑆𝑆�������� sSBP 𝑝𝑝𝐷𝐷𝑆𝑆𝑆𝑆𝑆𝑆 ∆𝑝𝑝𝐷𝐷𝑆𝑆𝑆𝑆�������� sDBP 
1 60 3.8 1.3 30 9.4 0.5 
2 80 6.0 1.6 50 5.8 1.1 
3 100 3.2 0.4 65 7.4 0.9 
4 120 5.2 0.4 80 8.0 0.0 
5 150 7.6 0.5 100 10.0 0.0 
6 200 11.0 2.3 150 15.2 0.4 
7 255 13.6 0.9 195 19.6 0.5 
Finally, the total mean arithmetic error values of the 
meters, including sample standard deviations, were 
calculated, see Table 5 and Table 6. 
Table 5: Total errors obtained using the FLUKE BP 
Pump 2. 
 ∆𝑝𝑝𝑆𝑆𝑆𝑆𝑆𝑆�������� 
(mmHg) 
sSBP 
(mmHg) 
∆𝑝𝑝𝐷𝐷𝑆𝑆𝑆𝑆�������� 
(mmHg) 
sDBP 
(mmHg) 
Hartmann 
Digital HG 
160 
2.3 1.1 5.3 1.3 
HuBDIC 
HBP–1520 
0.4 1.0 1.9 1.8 
Table 6: Total errors obtained using the FLUKE 
Prosim 8. 
 ∆𝑝𝑝𝑆𝑆𝑆𝑆𝑆𝑆�������� 
(mmHg) 
sSBP 
(mmHg) 
∆𝑝𝑝𝐷𝐷𝑆𝑆𝑆𝑆�������� 
(mmHg) 
sDBP 
(mmHg) 
Hartmann 
Digital HG 
160 
8.0 5.1 9.7 3.7 
HuBDIC 
HBP–1520 
7.2 3.8 10.8 4.9 
Results of statistical analysis 
The complete set of the data has been used for the 
statistical analysis. Both for SBP and DBP, and both for 
FLUKE BP Pump 2 [21] and FLUKE Prosim 8 [22], all 
five measurements for all seven presets has been collect-
ed. It means that each data collection was a set of 35 
values. 
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Using the Lilliefors test, the null hypotheses H0: the 
data comes from a normal distribution, have been 
rejected for all datasets (p < 0.05). Consequently, using 
the Wilcoxon rank-sum test, the significant differences 
between the simulators have been proved for all mea-
surements – both for SBP and DBP measurements and 
both for Hartmann Digital HG 160 and HuBDIC HBP–
1520 tonometers (p < 0.001). 
Discussion 
The results show that both tested blood pressure 
monitors met the requirements of the regulation MP 017 
[18] and can be used for providing health care in the 
Czech Republic. However, the results of the total error 
test (according to Slovak Decree No. 210/2000 Coll. 
[20]) of devices using calibrated blood pressure simu-
lators are ambiguous. The mean differences obtained 
using the FLUKE BP Pump 2 are typically lower than 
the corresponding values obtained using FLUKE Prosim 
8. Only HuBDIC HBP–1520 met the criteria, and only 
when tested with the Fluke BP Pump 2 blood pressure 
simulator. In all other cases, one or both required criteria 
were not met. The result of the metrological control is 
thus greatly influenced by the choice of a blood pressure 
simulator. The differences between the two simulators 
are statistically significant. This observation is in line 
with the conjecture on about the practical applicability 
of blood pressure simulators to determine clinical 
accuracy. Even in the EN 1060–3 [19] is note under 
point 3.6 Patient simulator: „The devices are not used 
for testing accuracy but is required in assessing stability 
of performance.” This is also reported by some manu-
facturers of the patient simulators (Fluke) [25]: „The 
NIBP simulator is used to evaluate the performance of 
NIBP monitors. NIBP accuracy is determined by static 
pressures, whether generated by the NIBP simulator or 
other pressure source that is traceable to national 
metrology standards. A well-designed simulator should 
mimic the dynamic nature of the NIBP patient and create 
a stable response of the living subject to the cuff during 
the measurement cycle. Therefore, it is possible to use 
a simulator to determine the repeatability of these moni-
tors.” Some manufacturers of blood pressure monitors 
are also in favor of this conclusion [26]: „NIBP modules 
from different manufacturers will usually give different 
results on the same simulator setting. This is normal 
and expected primarily due to a number of algorithm 
differences between manufacturers. THE OEM NIBP 
MODULE THAT BEST MATCHES UP WITH 
TARGET VALUES IS NOT NECESSARILY THE 
BETTER MODULE. Remember, NIBP simulators can-
not be used to measure clinical accuracy.” 
At all presets, the tested devices had a very good 
repeatability of the measurements, as evidenced by the 
overall repeatability (the average of the standard 
deviations for each preset). However, the total sample  
standard deviation in the evaluation of the procedure is 
not taken as the average of those individual series of 
measurements at each preset, but as the standard of all 
measurements across all presets, so the resulting stan-
dard deviation of the whole set is significantly higher. 
Such a method of evaluating sample standard deviation 
is suitable when conducting clinical trials according to 
validation protocol (AAMI [5], BHS [6, 7], ESH [8], EN 
1060–4 [15] etc.) on a patient population. The authors 
consider the use of such evaluation procedure with 
blood pressure simulators as slightly problematic. Cur-
rent simulators are not yet able to replace real patients, 
they still have technical limits and it is not advisable to 
use them to test the overall accuracy with oscillometric 
devices. Some problems of using simulators for valida-
tion of blood pressure monitors are also discussed in 
[27]. In spite of it, a development of simulators which 
might be used for blood pressure monitors testing is still 
in progress [28]. 
In addition, the blood pressure monitors that allow 
simultaneous measurement by an auscultation method 
on the same arm are at a disadvantage, as testing under 
(a) Decree No. 210/2000 Coll. [20] is, in our opinion, 
very demanding. It is necessary to have the consent of 
the persons for the measurement, and in addition, it is 
necessary to have persons with different blood pressure 
values, which can make it very difficult to perform 
metrological verification itself in clinical practice. The 
cost of such metrological verification is certainly also 
questionable. The price of a calibrated blood pressure 
simulator is not negligible, and the overall range of tests, 
where several repetitive measurements are performed, 
is time consuming. Therefore, the price of metrological 
verification is almost certainly at least comparable to the 
purchase price of commonly available electronic blood 
pressure monitors used in healthcare facilities. This fact 
could lead the healthcare providers rather to a regular 
replacement of instrumentation than the implementation 
of metrological verification of older devices (environ-
mentally high load), or in the worst case, the absence of 
regular controls (hazard for humans). 
Non-invasive automatic sphygmomanometers cur-
rently marketed must now undergo a clinical test accord-
ing to one of the procedures described in EN 81060–2 
[12]. For this reason, the authors believe that regular 
checks of the static accuracy of the cuff indication as 
recommended in the EN 80601–2–30 + A1 [11] stan-
dard can be considered as sufficient verification of the 
accuracy of the blood pressure monitors. 
In the course of work on this article, new legislation 
concerning metrological inspections of measuring 
instruments came into force in Slovakia. It is the Decree 
No. 161/2019 Coll. [29] Annex No. 37 which deals with 
metrological checks of non-invasive blood pressure 
devices. This Annex no longer describes the exact 
technical procedure for checking these devices, but 
paragraph 6.2.4 states the obligation to test the overall 
accuracy of the system using a blood pressure simulator. 
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Conclusion 
In this paper, the suitability of using a blood pressure 
simulator to determine the overall error (clinical 
accuracy) of two automated non-invasive oscillometric 
blood pressure monitors was examined. The overall 
error was evaluated using two calibrated blood pressure 
simulators for two commercial blood pressure monitors. 
The differences between the two simulators were 
statistically significant – both for SBP and DBP mea-
surements and both for Hartmann Digital HG 160 and 
HuBDIC HBP–1520 tonometers (p < 0.001). Without 
precise knowledge of the relationship between the blood 
pressure monitor and the simulator used, it is not 
appropriate to use simulators to determine the overall 
error. On the other hand, the tested devices had a very 
good repeatability of the measurements at all presets, 
with both simulators. From this point of view, it is better 
to use simulators to determine the stability of measure-
ment by a given tonometer rather than its clinical accu-
racy. 
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